Vimarsana
Biggest News Aggregation in the World

Page 43 - Small Molecules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Molecules Today - Breaking & Trending Today

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma - Vimarsana News

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma

LUXEMBOURG, Feb. 1, 2022 /PRNewswire/ -- CordenPharma, a leading, full-service Contract Development & Manufacturing Organization (CDMO) supplying APIs, Excipients, Drug Products, and associated

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma - Vimarsana News

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma

/PRNewswire/ -- CordenPharma, a leading, full-service Contract Development & Manufacturing Organization (CDMO) supplying APIs, Excipients, Drug Products, and...

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma - Vimarsana News

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma

/PRNewswire/ -- CordenPharma, a leading, full-service Contract Development & Manufacturing Organization (CDMO) supplying APIs, Excipients, Drug Products, and...

Lonza Delivers Strong 2021 performance with 20% CER Sales Growth - Vimarsana News

Lonza Delivers Strong 2021 performance with 20% CER Sales Growth

DJ Lonza Delivers Strong 2021 performance with 20% CER Sales Growth Lonza Group AG / Key word(s): Annual Results Lonza Delivers Strong 2021 performance with 20% CER Sales Growth 26-Jan-2022 / 07:00

Cullinan Oncology Forms Strategic Collaboration Agreement with Mount Sinai to Advance Oral HPK1 Protein Degrader for Cancer Treatment - Vimarsana News

Cullinan Oncology Forms Strategic Collaboration Agreement with Mount Sinai to Advance Oral HPK1 Protein Degrader for Cancer Treatment

Collaboration to identify and advance best-in-class HPK1 protein degraders Exclusive option for Cullinan to license related intellectual property from the collaboration CAMBRIDGE, Mass.,... | January 10, 2022